1 Grantham JA, Borgeson DD, Burnett JC.BNP:pathophysiological and potential therapeutic roles in acute congestive heart failure[J]. Am J physiol, 1997;272:R1077-83
2 Stein BC, Levin RI.Natriuretic peptides:phy siology, therapeutic potential, and risk stratification in ischemic heart disease[J]. Am Heart J, 1998;135:914-23
3 Nakagawa O, Ogawa Y, Itoh H, S Suga, Komatsu Y, Kishimoto I, et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy: evidence for brain natriuretic peptide as an “emergency” cardicac hormone against ventricular overload[J]. J Clin Invest,1995;96:1280-7
4 Maeda K, Tsutamota T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction[J]. Am Heart J, 1998;135:825-32
5 Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompsom SG, Pode-Wilsom PA, et al. Value of natriuretic peptide in assessment of patients with possible new heart failure in primary care[J]. Lancet, 1997;350:1349-53
6 Mcdonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrisou CE, et al. Biochemical detection of left ventricular systolic dysfunction[J]. Lancet, 1998;351:9-13
7 Maisel AS, Krishnaswamy P, Nowak RM, Mccovd J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure[J]. N Engl J Med, 2002;347:161-7
8 Suzuki T, Yamaoki K, Nakajima O, Yamazaki T, yamada Y, Akioka H, et al. Screening for cardiac dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels[J]. Jpn Heart J, 2000;41:205-14
9 Bettencourt P, Ferreira A, Dias P, Castro A, Martins L, Cergueira-Ctomes M.Evaluation of brain natriuretic peptide in the diagnosis of heart failure[J]. Cardiology, 2000;93:19-25
10 Dao Q, Krishnaswamy P, Kazanegra R, Harrison A, Amirnovin R, Lenert L, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgentcare setting[J]. J Am Coll Cardiol, 2001;37:379-85
11 Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel A.Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea[J]. J Am Coll Cardiol,2002;39:202-9
12 Harrison A, Morrison LK, Krishnaswamy P, Kazanegra R, Clopton P, Dao Q, et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea[J]. Ann Emerg Med, 2002;39:131-8
13 Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure[J]. Circulation,2002;105:2392-7
14 Richards AM, Nicholls MG, Yandle TG, Ikram H, Espiner EA, Turner JG, et al. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction[J]. Heart, 1999;81:114-20
15 Tsutamoto T, Wada A, Maeda K, Hisanaga T, Mabuchi N, Hayashi M, et al. Plasma brain natriuretic peptide level as a biochemical mark of morbidity and mortality in patients with asymptomatic or symptomatic left ventricular dysfunction[J]. Eur Heart J, 1999;20:1799-807
16 Mills RM, Lejemtel TH, Hortou DP, Liang C, Lang R, Silver MA, et al. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure[J]. J Am Coll Cardiol, 1999;34:155-62
17 Elsener D, Muntze A, Kromer EP, Riegger GA.Effectiveness of endopeptidase inhibition (Candoxatril) in congestive heart failure[J]. Am J Cardiol, 1992;70:494-8
18 Hobbs RE, Miller LW, Bott-Silverman C, James KB, Rincon G, Grossbarb EB.Hemodynamic effects of a single intrenous injection of synthetic human brain natriuretic peptide in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy[J]. Am J Cardiol, 1996;78:896-901
19 Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM.Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations[J]. Lancet, 2000;355:1126-30
20 Cheng V, Kazanagra R, Garcia A, Lenert L, Krishnaswamy P, Gardetto N, et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure:a pilot study[J]. J Am Coll Cardiol, 2001;37:386-91
21 Richards AM, Doughty R, Nicholls MG, Macmallsn S, Ikram H, Sharpe N, et al. Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction[J]. Circutation, 1999;99:786-92
22 Struthers AD.How to use natriuretic peptide levels for diagnosis and prognosis[J]. Eur Heart J, 1999;20:1374-5 |
